Industry News
OpenAI's venture fund and Arianna Huffington's Thrive Global are leading the investment in Thrive AI Health, a startup focused on creating an AI health coach to promote healthier lifestyles. Led by CEO DeCarlos Love, the company aims to democratize expert-level health coaching to address chronic diseases through personalized, AI-driven advice on sleep, food, fitness, stress management, and connection. Thrive AI Health is partnering with Stanford Medicine, the Alice L. Walton School of Medicine, and the Rockefeller Neuroscience Institute. The Alice L. Walton Foundation is also a strategic investor.
NeuroBrave, a leader in cognitive and emotional technologies, has been accepted into the Google AI Startups Program and received investment from the Google AI Fund. This program supports promising AI startups. NeuroBrave's technology leverages advanced signal processing, deep learning, and generative AI to provide real-time mental health solutions through wearables and digital services. CEO Dror Talisman expressed excitement for the support, aiming to expand their reach and improve global mental health. NeuroBrave's clients include major organizations like Qualcomm and Garmin.
The U.S. Economic Development Administration awarded $49 million to the Wisconsin BioHealth Tech Hub to position Wisconsin as a leader in personalized medicine. The Medical College of Wisconsin (MCW), a key partner in the 18-member consortium, leads the CAREScan Mobile Screening project. This initiative aims to enhance health equity through neighborhood-based cancer screenings and AI-enabled telehealth, developed by NexusMD. MCW President John R. Raymond, Sr., MD, praised the collaboration and BioForward's leadership in advancing biohealth. The project focuses on building community trust and participation, particularly in underserved areas, and will be based at MCW's Milwaukee campus.
Innovaccer, a healthcare SaaS firm, is set to receive a $20 million investment from the International Finance Corporation (IFC). This investment aligns with Innovaccer's goal to secure $200 million in Series F funding, with interest from Kaiser Permanente and Mubadala Capital. Headquartered in San Francisco, Innovaccer operates primarily in the US, India, and the Middle East. The company, valued at $3.2 billion in 2021, integrates healthcare data for hospitals and insurers, claiming $1.5 billion in cost savings from 50 million unified patient records. Innovaccer aims to reach $200 million in annual revenue and profitability by 2024 through acquisitions.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
© Healthcare Development & Innovation Group LLC. All Rights Reserved 2024.